Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Wound healing presents significant clinical challenges, particularly among immunocompromised individuals and patients suffering from chronic systemic conditions such as diabetes. These patient groups are more prone to postoperative complications and frequently experience delayed healing processes. Under normal physiological conditions, wound healing follows a cascade that heavily depends on the formation of granulation tissue, where blood vessels play a crucial role. As the healing tissue matures, the density of these vessels diminishes. However, in diabetic individuals, impaired immune responses and defective neovascularization significantly hinder this process. Interestingly, the oral mucosa demonstrates a unique healing pattern-characterized by a reduced vascular response yet more mature and efficient capillaries. This feature promotes enhanced oxygen delivery to regenerating tissues and contributes to faster healing. A key factor impeding effective wound healing is insufficient tissue oxygenation, often caused by compromised vascular supply. This deficiency adversely affects leukocyte-mediated bacterial clearance and tissue regeneration. Oxygen is vital not only for cellular repair mechanisms but also for its antimicrobial effects, particularly through oxidative microbial destruction.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
Egypt
-
Ismailia、Egypt、エジプト
- Faculty of dentistry Suez canal university
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
-
Age ≥ 18 years (able to sign informed consent).
-
Requires extraction of at least one hopeless tooth meeting one or more of the following:
- Furcation involvement > Class II -Tooth mobility > Grade II
- Probing pocket depth (PPD) > 6 mm
- Alveolar bone loss ≥ 70% of root length
- Persistent radiographic pathology or chronic symptoms (e.g., pain, fistula, infection)
- Non-restorable condition
-
The case can be prepared for implant placement
Exclusion Criteria:
- General contraindications to surgery
- Pregnancy or breastfeeding
- Uncontrolled diabetes
- Current or previous intravenous bisphosphonate therapy
- History of allergic reaction to the applied gel or any of its components
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Study with BlueM gel
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
|
プラセボコンパレーター:Control without BlueM gel
Standard postoperative care without the use of the gel, allowing for natural healing. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Post-operative pain
時間枠:1, 3 and 7 days
|
Post-operative pain levels assessed using the Visual Analog Scale (VAS), where higher scores indicate worse outcomes (more pain). Minimum score = 0 (No pain); Maximum score = 10 (Severe pain that completely prevents daily activities). |
1, 3 and 7 days
|
|
post-operative complications
時間枠:1, 3 and 7 days
|
Measure the incidence of post-operative complications (e.g., dry socket, infection) in both groups. |
1, 3 and 7 days
|
|
Clinical signs of inflammation
時間枠:1, 3 and 7 days
|
Clinical signs of inflammation assessed using an ordinal clinical grading scale for swelling, where higher scores indicate worse outcomes (more severe inflammation). Scale ranges from 1 to 4: 1 = none (no visible swelling), 2 = mild (intraoral swelling in the surgical zone), 3 = moderate (extraoral swelling in the surgical zone), and 4 = severe (extraoral swelling extending beyond the surgical zone and visible hematoma and ecchymosis). |
1, 3 and 7 days
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in Bone Density and Vertical Bone Height Assessed by Cone-Beam Computed Tomography (CBCT)
時間枠:Immediately and 6 months post-operatively
|
Assessment of bone regeneration promoted by the oxygen-releasing oral gel. Vertical bone height will be measured in millimeters (mm) and bone density will be evaluated using CBCT scans immediately and 6 months post-operatively. |
Immediately and 6 months post-operatively
|
|
Histomorphometric Analysis of Bone Quality Using H&E and Masson's Trichrome Staining
時間枠:6 months post-operatively
|
Assessment of bone quality evaluated by histomorphometric analysis of tissue sections stained with Hematoxylin and Eosin (H&E) and Masson's Trichrome. The measurement quantifies the distribution and number of osteoblasts and osteocytes, as well as the maturation of bone (differentiating between woven and lamellar bone) at 6 months post-operatively. Higher maturation of lamellar bone and balanced cellular distribution indicate better outcomes. |
6 months post-operatively
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: a review of the literature. Dermatol Surg. 2008 Sep;34(9):1159-69. doi: 10.1111/j.1524-4725.2008.34254.x. Epub 2008 May 29.
- Alshehri, F.A., 2023. Role of Topical Oxygen Oral Therapy in Wound Healing of Oral and Periodontal Tissues: A Narrative Review. Pakistan Oral & Dental Journal, 43(3), pp.106-113.
- Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016 Jul;13 Suppl 2(Suppl 2):5-15. doi: 10.1111/iwj.12623.
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- 2025/1005
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。